… patients failed to find a superiority of citalopram till 40 mg/day than … with schizophrenia
show the effectiveness of paroxetine on negative symptoms of schizophrenia, but more evidence …

… In summary, the current lack of evidence exacerbates the challenge of … Citalopram as an
adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophrenia. Int …

… presentation of schizophrenia encompasses symptoms divided into three dimensions: positive…
To date, studies specifically investigating NS in schizophrenia are scant; therefore, proper …

… In summary, the current lack of evidence exacerbates the challenge of … Citalopram as an
adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophrenia. Int …

… for schizophrenia in … serotonin selective reuptake inhibitors or mirtazapine, but one recent
study indicated that duloxetine seems to be a tolerable and efficacious agent, as an adjuvant …

… Further evidence from the clinical trials is essential to … Dopamine and serotonin levels were
shown to be higher in research … helveticus was given every day during stress, and citalopram …

… The schizophrenia studies (n = 2) found adjuvant probiotic … use of adjuvant probiotic treatment
with selective serotonin reuptake … Probiotic adjuvant treatment with antipsychotics could be …

… which are potentially compatible to positive symptoms of schizophrenia [93,94], in that they
are associated with increased dopaminergic and serotonergic transmission in the brain [95,96…

… evidence regarding the effectiveness of beta blockers as an adjuvant therapy for the treatment
of schizophrenia … considerable evidence for alterations in serotonin level in schizophrenia …

… One advantage of adjuvant pharmacotherapy is the avoidance of pharmacotherapy lag time
… of adding citalopram to a clozapine treatment regimen in patients with schizophrenia by …